Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2024 ∙ Vasconcelos, D. A. Santos, A. M. D. Nascimento, J. C. Silva, Ctds Menezes, A. F. Barreiro, Mdsc Ferreira, C. B. T. Silva, G. M.

Educational interventions for the prevention and management of adverse events following immunisation: a systematic review

  • Healthcare workers
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Cao, Q. Hou, Y. Wang, C. Yin, J.

Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: A systematic review and meta-analysis

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Gebreyesus, A. Tesfay, K.

Effect of maternal education on completing childhood vaccination in Ethiopia: systematic review and meta-analysis

  • Africa
  • Ethiopia
  • Children
  • Tuberculosis
  • Poliomyelitis
  • Diphtheria
  • Tetanus
  • Hepatitis B
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Measles
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Goryaynov, S. Gurova, O.

Effect of Platform Type on Clinical Efficacy of SARS-CoV-2 Vaccines in Prime Vaccination Settings: A Systematic Review and Meta-Regression of Randomized Controlled Trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Sepúlveda-Pachón, I. T. Dunne, E. M. Hanquet, G. Baay, M. Menon, S. Jodar, L. Gessner, B. D. Theilacker, C.

Effect of pneumococcal conjugate vaccines on viral respiratory infections: a systematic literature review

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Moderate
2024 ∙ Jain, M. Duvendack, M. Shisler, S. Parsekar, S. S. Leon, M. D. A.

Effective interventions for improving routine childhood immunisation in low and middle-income countries: a systematic review of systematic reviews

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Diphtheria
  • Pertussis
  • Tetanus
  • Measles
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Griskaitis, M. Thielemann, I. Schonfeld, V. Falman, A. Scholz, S. Reinacher, U. Haas, L. Wichmann, O. Harder, T.

Effectiveness and duration of protection of primary and booster immunisation against meningococcal serogroup C disease with meningococcal conjugate C and ACWY vaccines: Systematic review

  • Newborn
  • Children
  • Adolescents
  • Meningococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Fernández-García, S. Del Campo-Albendea, L. Sambamoorthi, D. Sheikh, J. Lau, K. Osei-Lah, N. Ramkumar, A. Naidu, H. Stoney, N. Sundaram, P. Sengupta, P. Mehta, S. Attarde, S. Maddock, S. Manning, M. Meherally, Z. Ansari, K. Lawson, H. Yap, M. Kew, T. Punnoose, A. Knight, C. Sadeqa, E. Cherian, J. Ravi, S. Chen, W. Walker, K. O'Donoghue, K. van Wely, M. van Leeuwen, E. Kostova, E. Kunst, H. Khalil, A. Brizuela, V. Kara, E. Kim, C. R. Thorson, A. Oladapo, O. T. Mofenson, L. Gottlieb, S. L. Bonet, M. Moss, N. Zamora, J. Allotey, J. Thangaratinam, S. Preg, C. O. V. Living Systematic Review Consortium

Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Li, K. Xia, Y. Ye, H. Sun, X. Shi, B. Wu, J.

Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Bengolea, A. Chamorro, F. Ramos, J. T. Rada, G. Catalano, H. N. Izcovich, A.

Effectiveness and safety of the recombinant herpes zoster vaccine in different population groups: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Herpes zoster
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...